Back
Dave Vs. Neurogene Industry Stock Comparison
Buy
81
DAVE
Dave
Last Price:
84.12
Seasonality Move:
54.31%
Sell
14
NGNE
Neurogene
Last Price:
23.30
Seasonality Move:
32.14%
Buy
81
Dave (DAVE)
is a Buy
Is Dave a Buy, Sell or Hold?
- The current Dave [DAVE] share price is $84.28. The Score for DAVE is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
- DAVE is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
14
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $23.31. The Score for NGNE is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
DAVE Stock Price Chart
DAVE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 9.52 | Buy |
Relative Strength Index (14 RSI): | 58.09 | Buy |
Chaikin Money Flow: | -303503 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (57.8 - 94.08) | Buy |
Bollinger Bands (100): | (28.65 - 66.61) | Buy |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.06 | Sell |
Relative Strength Index (14 RSI): | 38.34 | Sell |
Chaikin Money Flow: | -147367 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.21 - 54.47) | Sell |
Bollinger Bands (100): | (28.85 - 50.79) | Sell |
DAVE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 90.6 | Sell |
20-day SMA: | 83.92 | Buy |
50-day SMA: | 58.84 | Buy |
200-day SMA: | 42.85 | Buy |
8-day EMA: | 88.12 | Sell |
20-day EMA: | 80.84 | Buy |
50-day EMA: | 65.27 | Buy |
200-day EMA: | 43.63 | Buy |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.65 | Sell |
20-day SMA: | 27.57 | Sell |
50-day SMA: | 41.32 | Sell |
200-day SMA: | 38.35 | Sell |
8-day EMA: | 23.58 | Sell |
20-day EMA: | 28.68 | Sell |
50-day EMA: | 36.02 | Sell |
200-day EMA: | 36.13 | Sell |
Dave Earnings Growth & DAVE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.65 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.83 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.04 per share.
Dave Technical Analysis
Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
25 | 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
25 | 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |